In 335 newly diagnosed MM patients, NY-ESO-1 expression was present in 60% of cases in patients with cytogenetic abnormalities vs. 31% of cases with no abnormalities; this number increased to 100% and 61% at relapse, respectively (208). This evidence concerns the gene CTAG1B and Miyoshi myopathy.